2023 Form 5500 filing — Cenexel Clinical Research, Inc. 401(K) Plan
Plain-English filing summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20240925122206NAL0025386208001) for Cenexel Clinical Research, Inc. 401(K) Plan, reported by Cenexel Clinical Research, Inc. under EIN 83-1353724 and plan number 001. It reports 1,097 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).
- EFAST2 acknowledgement
- 20240925122206NAL0025386208001
- Filing year
- 2023
- Form type
- 2
- Plan sponsor
- Cenexel Clinical Research, Inc.
- EIN
- 83-1353724
- Plan number
- 001
- Location
- Salt Lake City, UT
- Participants
- 1,097
- Schedules available
- Schedule H, Schedule C
- Received date
- not reported in the loaded dataset
Reported financial snapshot (2023)
- Total assets (EOY)
- $10,061,034
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $10,061,034
- Employer contributions
- $397,704
- Participant contributions
- $2,190,801
- Total income / additions
- $4,242,429
- Benefits paid
- $1,765,970
- Administrative expenses
- $80,098
- Total expenses
- $1,849,183
- Net increase / (decrease)
- $2,393,246
- Schedule source
- Schedule H
Reported service provider compensation (Schedule C)
| Provider | Service | Direct comp. | Indirect comp. |
|---|---|---|---|
| Principal Life Insurance Company | CONTRACT ADMINISTRATOR | $80,097 | $0 |
| Alera Investment Advisors, LLC | INVESTMENT ADVISORY | $0 | $23,780 |